Calyxt

Calyxt, Inc. is technology company. engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as Canola, Rice, Soybean, Corn and Wheat. The company was founded by Rory Riggs, Peter Beetham and Greg Gocal in 2010 and is headquartered in San Diego, CA.

ROSEVILLE, Minn., Jan. 4, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company today announced that a presentation given by management at the H.C Wainwright BioConnect Conference will be available for viewing online on Monday, January 10, 2022 at 7:00 a.m.

Calyxt to Present at the H.C. Wainwright BioConnect Virtual Conference

BIOLASE

Clearside Biomedical

CohBar

ObsEva

Predictive Oncology Inc

Vista Gold

Penny stocks under $3 are full of potential and potential pitfalls. These are relatively safe and worth your consideration.

7 of the Best Penny Stocks Under $3 for 2022 to Buy Now

ROSEVILLE, Minn., Dec. 8, 2021 /PRNewswire/ -- Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the completion of a key milestone in its lab-scale BioFactory™ manufacturing system.

Calyxt Identifies More Than 15,000 Unique Chemical Signatures in Lab-Scale BioFactory™ Production Run

ROSEVILLE, Minn., Dec. 6, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the hiring of two senior roles important to furthering Calyxt's recently announced strategic direction.

Calyxt Announces Strategic Hires in AI/ML and Technology Licensing

ROSEVILLE, Minn., Nov. 23, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that management will present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum.

Calyxt to Present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum

Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q3 2021 Results - Earnings Call Transcript

Calyxt (CLXT) delivered earnings and revenue surprises of -26.32% and 69.48%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Calyxt (CLXT) Reports Q3 Loss, Tops Revenue Estimates

ROSEVILLE, Minn., Nov. 4, 2021 /PRNewswire/ --  Calyxt, Inc.  (NASDAQ: CLXT), a plant-based synthetic biotechnology company, today announced financial results for its third quarter ended September 30, 2021.

Calyxt Reports Third Quarter 2021 Financial Results

Clear Channel Outdoor Holdings

Check-Cap

Geron

KULR Technology Group

Some of the best penny stocks 2021 has offered were some of… The post 5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175%

Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Calyxt (CLXT) Report Negative Earnings Next Week? What You Should Know

ROSEVILLE, Minn., Oct. 19, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) will hold a conference call on Thursday, November 4, 2021, at 4:30 p.m.

Calyxt to Host third Quarter 2021 Financial Results Conference Call on Thursday, November 4, 2021, at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., Oct. 12, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the appointment of Seth Dobrin, Ph.D.

Calyxt Names IBM's Global Chief Artificial Intelligence Officer, Dr. Seth Dobrin, to Scientific Advisory Board

ROSEVILLE, Minn., Oct. 5, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will focus the Company on engineering synthetic biology solutions for a diversified base of customers across an expanded group of end markets including the nutraceutical, cosmeceutical, pharmaceutical, advanced materials, and chemical industries.

Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded Group of End Markets and Diversified Base of Customers

Calyxt Inc (NASDAQ: CLXT) has entered into a research collaboration with a food ingredient manufacturer based in Asia to develop an improved soybean to produce oil as a commercial alternative to palm oil. As part of the research collaboration, Calyxt will receive cash payments in each of the two years of its term.

Calyxt Seeks To Develop Palm Oil Alternative

ROSEVILLE, Minn., Sept. 28, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based technology platform company, today announced it entered into a research collaboration with a leading global food ingredient manufacturer based in Asia to develop an improved soybean capable of producing an oil as a commercial alternative to palm oil.

Calyxt Announces Collaboration with Leading Global Food Ingredient Manufacturer to Develop Palm Oil Alternative

ROSEVILLE, Minn., Sept. 7, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology platform company, today announced that a presentation given by management at the H.C Wainwright 23rd Annual Global Investment Conference will be available for viewing online on September 13 th at 7:00 a.m.

Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference

Amplify Energy Corp.

Baudax Bio

ReShape Lifesciences

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

5 Penny Stocks Insiders Are Buying

Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2021 Results - Earnings Call Transcript

Shares of Calyxt (NASDAQ:CLXT) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 36.36% over the past year to ($0.21), which missed the estimate of ($0.19).

Calyxt: Q2 Earnings Insights

S&W Seed

ROSEVILLE, Minn., Aug. 5, 2021 /PRNewswire/ --  Calyxt, Inc.  (NASDAQ: CLXT), a plant-based technology company, today announced financial results for its second quarter ended June 30, 2021.

Calyxt Reports Second Quarter 2021 Financial Results

ROSEVILLE, Minn., Aug. 4, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based biotechnology platform company, today announced that management will present at the Canaccord Genuity 41st Annual Growth Conference at 11:00 a.m.

Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021

Calyxt (CLXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

ROSEVILLE, Minn., July 27, 2021 /PRNewswire/ -- Calyxt, Inc.  (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced that, in accordance with the offer letter entered into on July 15, 2021, it has granted, effective July 27, 2021 (the "Grant Date"), an inducement award to Michael A.

Calyxt Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

ROSEVILLE, Minn., July 19, 2021 /PRNewswire/ --  Calyxt, Inc.  (NASDAQ: CLXT) will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m.

Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time

Biotechnology company Calyxt Inc (NASDAQ: CLXT) has appointed Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021.

News for Calyxt Stock (CLXT)